Mind Medicine’s share price has responded very strongly to Q3 update that contained very little new information. Read why I ...

DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

However, despite technological advancements, the absence of a clear clinical timeline has tempered ... cell types with limited off-target activity is seen as a unique and valuable asset in the ...

The timeline for NKTX remains long ... killer cell product that is hoped to be an "off-the-shelf" allogeneic cell therapy for B-cell malignancies and inflammatory conditions known to be driven ...

BriaCell’s clinical candidates for next generation breast cancer (Bria-BRES+™) and prostate cancer (Bria-PROS+™) generate robust anti-cancer ...

Intrigued by the recent news about Atlanta Hawks’ star Trae Young and his unexpected time off the court? With his injury ...

Most women don’t know what’s going to happen during perimenopause. Smart-ring manufacturers are stepping in to provide data ...

According to the American Stroke Association, more than 795,000 Americans experience a stroke annually, with balance issues ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Hello, ladies and gentlemen, and welcome to the Autolus ...

SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Ladies and gentlemen, thank you for joining us today. Welcome to ...

Today, we honor our local veterans and recognize their contributions to our Big Country community. Our 2024 Veterans Voices ...